Page last updated: 2024-09-05

sb 203580 and ps 540446

sb 203580 has been researched along with ps 540446 in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(ps 540446)
Trials
(ps 540446)
Recent Studies (post-2010) (ps 540446)
3,48941,137706

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)ps 540446 (IC50)
Chain A, Mitogen-activated protein kinase 14Homo sapiens (human)0.013
Chain A, Mitogen-activated protein kinase 14Homo sapiens (human)0.013
Mitogen-activated protein kinase 11Homo sapiens (human)0.062
Mitogen-activated protein kinase 14Homo sapiens (human)0.013

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Astolfi, A; Barreca, ML; Brea, J; Cannalire, R; Cecchetti, F; Cecchetti, V; Fallarino, F; Felicetti, T; Kudolo, M; Laufer, SA; Loza, MI; Manfroni, G; Manni, G; Massari, S; Palazzotti, D; Sabatini, S; Tabarrini, O1

Other Studies

1 other study(ies) available for sb 203580 and ps 540446

ArticleYear
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation.
    European journal of medicinal chemistry, 2019, Nov-15, Volume: 182

    Topics: Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Healthy Volunteers; Humans; Mitogen-Activated Protein Kinase 14; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship

2019